ReproNovo ApSActive
Key figures
32.401.199 kr.
Revenue 2024
Key ratios
202516,0%
Equity ratio
1,4×
Current ratio
54,8%
Return on equity
Balance sheet structure
Current assetsNon-current assetsLiabilities and provisionsEquity
Corporate tax
income year 20242024Taxable income 1.542.886 kr.339.416 kr.
Corporate tax →
Source: the Danish Tax Agency's public company tax lists. Calculated tax for the income year; may be lower than 22% of income, e.g. when tax is paid abroad. sktst.dk
Financial statements2024–2025
| 2024 | 2025 | |
|---|---|---|
| Balance sheet — assets | ||
| Cash and cash equivalents | 3.828.110 | 6.286.130 |
| Total current assets | 5.852.231 | 17.148.929 |
| Total non-current assets | 156.000 | 165.780 |
| Total assets | 6.008.231 | 17.314.709 |
| Balance sheet — liabilities and equity | ||
| Current liabilities | 4.753.810 | 12.324.650 |
| Non-current liabilities | — | 2.212.039 |
| Total liabilities | 4.753.810 | 14.536.689 |
| Share capital | 40.000 | 40.000 |
| Retained earnings of previous periods | 1.214.421 | 2.738.020 |
| Profit for the year | 1.214.421 | 1.523.599 |
| Total equity | 1.254.421 | 2.778.020 |
| Income statement | ||
| Sales revenue | 32.401.199 | — |
| Gross profit | — | 18.904.345 |
| Operating profit | 1.721.251 | 2.700.791 |
| Profit before income tax | 1.542.886 | 1.977.221 |
| Profit for the reporting year | 1.214.421 | 1.523.599 |
| Labour costs | 13.079.456 | 16.203.554 |
| Depreciation of non-current assets | — | — |
| Other indicators | ||
| Employees | 10 | 10 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
About the company
Annual report 2025Business reviewThe company's purpose is to research, develop and market therapeutic solutions for the treatment of diseases, as well as all activities that, in the opinion of the board of directors, are related thereto.
Excerpt from the management's review in the latest annual report.